Compare ConocoPhillips (COP) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ConocoPhillips vs Summit Therapeutics Inc — how do they compare? ConocoPhillips trades at $125.19 (market cap $151.27B), while Summit Therapeutics Inc trades at $15.56 (market cap $12.06B). The key difference: ConocoPhillips is far larger — about 12.5× Summit Therapeutics Inc's market cap, and ConocoPhillips pays a 2.67% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| COP | SMMT | |
|---|---|---|
Market Cap | $151.27B | $12.06B |
Sector | Energy | Health |
52-Week High | $133.80 | $26.98 |
52-Week Low | $85.66 | $12.55 |
Enterprise Value | $166.87B | $11.39B |
Dividend Yield | 2.67% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ConocoPhillips (COP) trades at $123.03, up 4.61% on the day, with a bullish technical signal from moving averages and strong Q2 2026 earnings beats. The company reported EPS of $3.24 versus $2.90 expected, driven by higher oil prices and Permian Basin output. Recent CEO transition to Andy O'Brien signals continuity, with a consensus analyst price target of $150.00 indicating 22% upside potential.
Outlook remains positive due to robust free cash flow growth and favorable commodity trends, though risks include oil price volatility and execution of the Alaska project. The stock offers value with a P/E of 16.66 and a net income margin of 14.65%, supported by a 74.51% buy rating from analysts.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ConocoPhillips
ConocoPhillips is a U.S.-based independent exploration and production firm. In 2021, it produced 1.0 million barrels per day of oil and natural gas liquids and 3.2 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2021 were 6.1 billion barrels of oil equivalent.
Read more on COP →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
